-
Combining Forces: Vemurafenib and Ipilimumab To Be Tried Together
Vemurafenib (ZelborafTM) was the second drug approved for metastatic melanoma this year. In …
-
From the Editors
Initial systemic therapies for cancer focused on the use of cytotoxic agents. The aim was to …
-
How Zelboraf (TM) (Vemurafenib), a New FDA-Approved Therapy, Extends Life For Patients with Metastatic Melanoma
Paul B. Chapman, MDAttending Physician Melanoma/Sarcoma ServiceMemorial …
